Rubella Virus Infected Macrophages and Neutrophils Define Patterns of Granulomatous Inflammation in Inborn and Acquired Errors of Immunity

Front Immunol. 2021 Dec 20:12:796065. doi: 10.3389/fimmu.2021.796065. eCollection 2021.

Abstract

Rubella virus (RuV) has recently been found in association with granulomatous inflammation of the skin and several internal organs in patients with inborn errors of immunity (IEI). The cellular tropism and molecular mechanisms of RuV persistence and pathogenesis in select immunocompromised hosts are not clear. We provide clinical, immunological, virological, and histological data on a cohort of 28 patients with a broad spectrum of IEI and RuV-associated granulomas in skin and nine extracutaneous tissues to further delineate this relationship. Combined immunodeficiency was the most frequent diagnosis (67.8%) among patients. Patients with previously undocumented conditions, i.e., humoral immunodeficiencies, a secondary immunodeficiency, and a defect of innate immunity were identified as being susceptible to RuV-associated granulomas. Hematopoietic cell transplantation was the most successful treatment in this case series resulting in granuloma resolution; steroids, and TNF-α and IL-1R inhibitors were moderately effective. In addition to M2 macrophages, neutrophils were identified by immunohistochemical analysis as a novel cell type infected with RuV. Four patterns of RuV-associated granulomatous inflammation were classified based on the structural organization of granulomas and identity and location of cell types harboring RuV antigen. Identification of conditions that increase susceptibility to RuV-associated granulomas combined with structural characterization of the granulomas may lead to a better understanding of the pathogenesis of RuV-associated granulomas and discover new targets for therapeutic interventions.

Keywords: granuloma treatments; granulomatous inflammation; inborn errors of immunity; macrophages; neutrophils; primary immunodeficiency; skin lesion; vaccine-derived rubella viruses.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Antigens, Viral / metabolism
  • Cohort Studies
  • Cytokines / metabolism
  • Disease Susceptibility
  • Female
  • Genetic Diseases, Inborn
  • Granuloma / immunology*
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Immunohistochemistry
  • Immunologic Deficiency Syndromes
  • Inflammation / immunology*
  • Macrophages / immunology*
  • Male
  • Middle Aged
  • Neutrophils / immunology*
  • Receptors, Interleukin-1 / antagonists & inhibitors
  • Rubella / complications
  • Rubella / immunology*
  • Rubella virus / physiology*
  • Th2 Cells / immunology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antigens, Viral
  • Cytokines
  • Receptors, Interleukin-1
  • Tumor Necrosis Factor-alpha